Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ICCM stock hub

IceCure Medical Ltd has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ICCMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

19.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ICCM

In the news

Latest news · ICCM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-188.8

P25 -106.6P50 -46.9P75 -3.1

ROIC-113.5

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ICCM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001584371
Company name	IceCure Medical Ltd
Country	Israel
Country code	US
Cusip	M53071136
Employees	69
Employees Change	3%
Employees Change Percent	4.55
Enterprise value	$10.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	IL0011224156
Last refreshed	2026-05-10
Market cap	$19.5M
Market cap category	Nano-Cap
Price	$0.24
Price currency	USD
Rev Per Employee	48,971.01x
Sector	Healthcare
Sic	3841
Symbol	ICCM
Website	https://www.icecure-medical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-77.28%
EV Sales Forward	1.33x
EV/Sales	3.2x
FCF yield	-74.99%
P/B ratio	1.94x
P/S ratio	5.77x
PS Forward	2.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	36.28%
Gross Profit	$1.2M
Gross Profit Growth	-15.51%
Gross Profit Growth Q	43.88%
Gross Profit Growth3 Y	-5.33%
Gross Profit Growth5 Y	-12.89%
Net Income	$-15.1M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-445.61%
Profit Per Employee	$-218,217
ROA	-71.29
Roa5y	-48.57
ROCE	-166.5
ROE	-188.8
Roe5y	-110.6
ROIC	-113.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.7%
Cagr3y	-40.2%
Cagr5y	-30.66%
EPS Growth Quarters	2
EPS Growth Years	3
Revenue Growth	2.67x
Revenue Growth Q	46.17x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	3.08x
Revenue Growth5 Y	-2.67x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.26
Assets	$13.9M
Cash	$8.9M
Current Assets	$12.6M
Current Liabilities	$4.8M
Debt	$217,000
Debt Equity	$0.02
Equity	$9.1M
Liabilities	$4.8M
Long Term Assets	$1.3M
Long Term Liabilities	$13,000
Net Cash	$8.7M
Net Cash By Market Cap	$44.55
Net Cash Growth	22.17%
Net Debt Equity	$-0.96
Tangible Book Value	$9.1M
Tangible Book Value Per Share	$0.12
WACC	13.05

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.61
Inventory Turnover	0.93
Net Working Capital	$-912,000
Quick ratio	1.96
Working Capital	$7.8M
Working Capital Turnover	$0.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-24.97%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75.68%
200-day SMA	0.7
3Y total return	-78.62%
50-day SMA	0.44
50-day SMA vs 200-day SMA	50under200
5Y total return	-83.96%
All Time High	12.4
All Time High Change	-98.06%
All Time High Date	2021-08-26
All Time Low	0.02
All Time Low Change	966.67%
All Time Low Date	2020-12-10
ATR	0.04
Beta	1.63
Beta1y	1.02
Beta2y	0.01
Ch YTD	-60.66
High	0.26
High52	1.4
High52 Date	2025-10-03
High52ch	-82.86%
Low	0.24
Low52	0.24
Low52 Date	2026-05-08
Low52ch	1.05%
Ma50ch	-45.11%
Premarket Change Percent	4
Premarket Price	$0.26
Premarket Volume	18,622
Price vs 200-day SMA	-65.87%
RSI	27.88
RSI Monthly	32.83
RSI Weekly	26.96
Sharpe ratio	-1.49x
Sortino ratio	-1.81
Tr YTD	-60.66
Tr1m	-27.27%
Tr1w	-20.35%
Tr3m	-59.32%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.04
Earnings Revenue Estimate	1,479,464x
Earnings Revenue Estimate Growth	104.06x
Operating Income	$-15.1M
Operating margin	-446.7
Price target	$2.5
Price Target Change	$942

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	44,295,003%
Float Percent	54.56%
Shares Insiders	45.44%
Shares Institutions	0.78%
Shares Out	81,180,045
Shares Qo Q	11.05%
Shares Yo Y	24.97%
Short Float	2.96%
Short Ratio	1.58
Short Shares	1.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-16M
Average Volume	532,241.3x
Bv Per Share	0.12
CAPEX	$-36,000
Ch1m	-27.27
Ch1w	-20.35
Ch1y	-77.25
Ch3m	-59.32
Ch3y	-80
Ch5y	-85
Ch6m	-65.17
Change	-4%
Change From Open	-4.38
Close	0.25
Days Gap	0.4
Depreciation Amortization	295,000
Dollar Volume	125,336.4
Earnings Date	2026-05-27
Earnings Time	bmo
EBIT	$-15.1M
EBITDA	$-14.8M
EPS	$-0.24
F Score	3
FCF	$-14.6M
FCF EV Yield	-135.24x
FCF Per Share	$-0.18
Financing CF	15,834,000
Fiscal Year End	December
Founded	2,006
Investing CF	-36,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-17
Last Report Date	2025-12-31
Last Split Type	Never
Last10k Filing Date	2026-03-17
Ma150	0.61
Ma150ch	-60.63%
Ma20	0.31
Ma20ch	-22.08%
Net CF	1,333,000
Next Earnings Date	2026-05-27
Open	0.25
Optionable	No
Position In Range	11.16
Post Close	0.24
Postmarket Change Percent	1.92
Postmarket Price	$0.24
Ppne	1,232,000
Pre Close	0.25
Price Date	2026-05-08
Ptbv Ratio	2.15
Relative Volume	0.98x
Revenue	3,379,000x
SBC By Revenue	40.63x
Share Based Comp	1,373,000
Tr6m	-65.17%
Volume	522,235
Z Score	-7.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ICCM pay a dividend?

Capital-return profile for this ticker.

Performance

ICCM stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ICCM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.8%

Float: +54.6% of shares outstanding

Insider ownership

+45.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ICCM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

27.9

Below 30: short-term oversold

Price vs 200-day MA

-65.9%

50/200-day relationship not available

Beta (5Y)

1.63

More volatile than the market

Sharpe ratio

-1.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ICCM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ICCM stock rating?

IceCure Medical Ltd is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ICCM analysis?

The full report lives at /stocks/ICCM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ICCM?

The latest report frames ICCM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ICCM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.